论文部分内容阅读
据《Jpn.J. Cancer Res.》2001年92卷第1期报道 干扰素(IFN)治疗可降低丙肝病毒(HCV)病人肝细胞癌(HCC)的发病率。日本大阪市大学医学院Shoji Kubo医生等,对施行肝切除术的159例连续的HCV相
According to Jpn. J. Cancer Res. 2001, Volume 92, Issue 1 Interferon (IFN) treatment reduces the incidence of hepatocellular carcinoma (HCC) in patients with hepatitis C virus (HCV). Dr. Shoji Kubo, School of Medicine, Osaka City University, Japan, etc., 159 consecutive HCV phases for hepatectomy